Skip to main content
Livermore
Livermore
ZHEN

Pacer Advisors, Inc.

SEC CIK
0001616667
Latest filing
Aug 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Pacer Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
369,451
Value
$230.4M
% of portfolio
0.6%
Quarters held
22
Since Q1 2021
Holdings of REGN by Pacer Advisors, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026369,451$230.4M0.6%+10,818+3.0%AddedHolders
Q1 2026358,633$277.1M0.8%−39,033−9.8%ReducedHolders
Q4 2025397,666$306.9M0.8%−47,659−10.7%ReducedHolders
Q3 2025445,325$250.4M0.6%+1910.0%AddedHolders
Q2 2025445,134$233.7M0.6%+37,764+9.3%AddedHolders
Q1 2025407,370$258.4M0.6%+390,374+2,296.9%AddedHolders
Q4 202416,996$12.1M<0.1%−2,544−13.0%ReducedHolders
Q3 202419,540$20.5M<0.1%+3,076+18.7%AddedHolders
Q2 202416,464$17.3M<0.1%+1,434+9.5%AddedHolders
Q1 202415,030$14.5M<0.1%+904+6.4%AddedHolders
Q4 202314,126$12.4M<0.1%+1,845+15.0%AddedHolders
Q3 202312,281$10.1M<0.1%+1,608+15.1%AddedHolders
Q2 202310,673$7.67M<0.1%−2,362−18.1%ReducedHolders
Q1 202313,035$10.7M<0.1%+6,810+109.4%AddedHolders
Q4 20226,225$4.49M<0.1%−256,440−97.6%ReducedHolders
Q3 2022262,665$180.9M1.3%+41,988+19.0%AddedHolders
Q2 2022220,677$130.4M1.0%+95,310+76.0%AddedHolders
Q1 2022125,367$87.6M0.7%+76,354+155.8%AddedHolders
Q4 202149,013$31.0M0.3%+38,907+385.0%AddedHolders
Q3 202110,106$6.12M0.1%−463−4.4%ReducedHolders
Q2 202110,569$5.90M0.1%+484+4.8%AddedHolders
Q1 202110,085$4.77M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.